Additional file 1. CDG state of the art until 2022: glycosylation pathways, phenotypes, genotypes, inheritance patterns, biomarkers, disease models, and treatments.
Text data of Fig. 7. ESI-Q mass spectrum of transferrin in various types of CDG. A (control), B (PMM2), C (ALG14), D (SLC35A2), E (SLC35A1), F (MAN1B1), G (PGM1) The mass spectral data (.txt or c
